National Center for Tumor Diseases (NCT)
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ungerechts, Guy
NCT05733611: RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Active, not recruiting
2
4
US
RP2, RP3, atezolizumab, bevacizumab
Replimune Inc., Roche Pharma AG
Refractory Metastatic Colorectal Cancer, pMMR, MSS
01/27
03/27
Schmidt, Martina E
BENEFIT, NCT02999074: Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Active, not recruiting
N/A
183
Europe
Resistance exercise, Aerobic exercise, Usual care during neoadjuvant chemotherapy/Exercise after surgery
German Cancer Research Center, University Hospital Heidelberg
Breast Cancer
07/23
07/24
NCT04921644: Longitudinal Investigation of Cancer-related Fatigue and Its Treatment (LIFT Project)

Recruiting
N/A
1400
Europe
German Cancer Research Center, Wuerzburg University Hospital, Baden-Württemberg Cancer Registry, German Research Foundation
Cancer-related Fatigue
08/23
02/24
MERLIN, NCT05448573: A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening

Recruiting
N/A
300
Europe
Fatigue Screening and assessment
German Cancer Research Center, National Center for Tumor Diseases, Heidelberg
Cancer-related Fatigue
06/25
09/25
Michel, Laura
POLAR, NCT06541769: CIPN-prevention Trial Evaluating the Efficacy of Hand-cooling and Hand-compression

Completed
N/A
122
Europe
Limb hypothermia, Limb compression
University Hospital Heidelberg
Chemotherapy-induced Peripheral Neuropathy, Onychodystrophy
07/22
07/22

Download Options